Literature DB >> 19932820

Anhedonia as predictor of clinical events after acute coronary syndromes: a 3-year prospective study.

Michel Leroy1, Gwenole Loas, Fernando Perez-Diaz.   

Abstract

BACKGROUND: Depression after acute coronary syndromes (ACS) is an important risk factor for further coronary events; but the influence of anhedonia, the decreased capacity to experience pleasure, has received little attention. The aim of the study was to investigate the effects of anhedonia on prognosis at 3-year follow-up in patients hospitalized for ACS.
METHOD: Consecutively admitted ACS patients (n = 291) completed the Chapman Physical Anhedonia Scale (PAS) and the Hospital Anxiety and Depression Scale depression subscale (HAD-D) at baseline (1-4 days after their admission). Two definitions of anhedonia were taken into account: dimensional definition using PAS score as well as categorical definition using several cutoff scores (hedonics: PAS less than 23 or 29; anhedonics: PAS equal to or greater than 23 or 29). Patients were followed during 3 years for adverse clinical events divided into severe cardiac events (mortality or myocardial infarction [MI]) and clinical events (mortality, MI, recurrence of ACS, hospital readmission, and onset or deterioration of heart failure).
RESULTS: At follow-up, there were 176 clinical events (36 deaths, 8 MIs, 58 ACS, 55 hospital readmissions, 19 heart failures). Dimensional anhedonia and depression were associated with poor prognosis, but anhedonia was the only predictor of severe cardiac events and clinical events after adjusting for demographic and clinical variables. Contrary to depression, categorical anhedonia (PAS >23) was an independent and significant predictor of severe cardiac events after adjusting for clinical variables. The incidence of death/MI in hedonics vs anhedonics was 11.1% vs 22.1% (hazard ratio = 2.18; 95% confidence interval, 1.11-4.26).
CONCLUSIONS: Dimensional and categorical anhedonias predicted independently severe cardiac events and clinical events after ACS.

Entities:  

Mesh:

Year:  2009        PMID: 19932820     DOI: 10.1016/j.comppsych.2009.01.011

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  7 in total

1.  Identifying symptom profiles of depression and anxiety in patients with an acute coronary syndrome using latent class and latent transition analysis.

Authors:  Mayra Tisminetzky; Bethany C Bray; Ruben Miozzo; Onesky Aupont; Thomas J McLaughlin
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

Review 2.  Psychological Aspects of Cardiac Care and Rehabilitation: Time to Wake Up to Sleep?

Authors:  Jonathan Gallagher; Giulia Parenti; Frank Doyle
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

3.  The Relationship between Smoking and Depression Post-Acute Coronary Syndrome.

Authors:  Andrew M Busch; Belinda Borrelli; Adam M Leventhal
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-02-01

Review 4.  Heartache and heartbreak--the link between depression and cardiovascular disease.

Authors:  Charles B Nemeroff; Pascal J Goldschmidt-Clermont
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

Review 5.  The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.

Authors:  Lydia Poole; Chris Dickens; Andrew Steptoe
Journal:  J Psychosom Res       Date:  2011-02-12       Impact factor: 3.006

6.  Depression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study.

Authors:  Phillip J Tully; Helen R Winefield; Robert A Baker; Johan Denollet; Susanne S Pedersen; Gary A Wittert; Deborah A Turnbull
Journal:  Biopsychosoc Med       Date:  2015-05-26

7.  Anhedonia as a Potential Risk Factor of Alzheimer's Disease in a Community-Dwelling Elderly Sample: Results from the ZARADEMP Project.

Authors:  David Vaquero-Puyuelo; Concepción De-la-Cámara; Beatriz Olaya; Patricia Gracia-García; Antonio Lobo; Raúl López-Antón; Javier Santabárbara
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.